Real-World Persistence with Anti-VEGF Therapy in Neovascular Age-related Macular Degeneration. [PDF]
Elham A +6 more
europepmc +1 more source
Safety of GBL1204-An Ophthalmic Bevacizumab in Prefilled Syringe for Neovascular Age-Related Macular Degeneration: A Phase I Study. [PDF]
Saraf A +11 more
europepmc +1 more source
Pharmacodynamics of Free VEGF After Treatment with the Port Delivery Platform with Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration. [PDF]
Maass KF, Maia M, Gune S, Chang MC.
europepmc +1 more source
High-Resolution and Multimodal Structural Phenotyping of Intermediate and Advanced Non-Neovascular Age-Related Macular Degeneration. [PDF]
Eandi CM +15 more
europepmc +1 more source
Clinical evaluation of faricimab in real-world neovascular age-related macular degeneration in India: a multicenter observational study. [PDF]
Chakraborty D +7 more
europepmc +1 more source
Predictors of 1-year fibrosis in treatment-naïve neovascular age-related macular degeneration: the role of baseline OCTA-derived MNV vessel density. [PDF]
Lin Y +5 more
europepmc +1 more source
Progressive intraocular inflammation with anterior scleritis following intravitreal Faricimab for neovascular age-related macular degeneration: a case report. [PDF]
Hsu CH, Chen AI, Lai CH, Chen NN.
europepmc +1 more source
Early Structure-Function Correlates in Neovascular Age-Related Macular Degeneration Using Artificial Intelligence-Derived OCT Biomarkers. [PDF]
Mares V +19 more
europepmc +1 more source
Real-World Outcomes of Faricimab in Patients with Highly Refractory Neovascular Age-Related Macular Degeneration in Portugal: The REVEAL Study. [PDF]
Mira F +14 more
europepmc +1 more source

